翰宇藥業(300199.SZ):子公司翰宇大理擬增資擴股引進大眾交通 公司放棄優先認購權
格隆匯 1 月 14日丨翰宇藥業(300199.SZ)公佈,子公司翰宇大理為滿足工業大麻種植及加工業務的發展需要,擬通過增資擴股引進戰略投資者大眾交通(集團)股份有限公司(“大眾交通”)。公司及其他原股東均放棄對翰宇大理增資所享有的優先認購權,此次增資完成後翰宇大理的註冊資本將由3131.8681萬元增至3549.4503萬元,公司的直接持股比例由32.5684%變更為28.7368%,合計持股比例為29.9133%。
此次增資後,翰宇大理的資本實力將進一步得到增強,發展基礎得到夯實,提高了翰宇大理的經營韌性,為工業大麻業務的有序推進提供了有力的支撐。此次增資引入戰略投資者,將充分利用和整合各方資源,有助於翰宇大理工業大麻種植及加工業務的進一步推進,有利於翰宇大理的長期發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.